[Extracorporeal lithotripsy in children. Report of 30 cases].

Objective: To evaluate the efficacy of extracorporeal lithotripsy in the treatment of urinary stones in children.

Material And Method: Thirty children (19 boys, 11 girls) with a mean age of 7 years (range: 14 months to 17 years) with a total of 32 urinary stones were treated by extracorporeal lithotripsy. The stone was situated in the kidney in 27 cases, the lumbar ureter in 4 cases and the pelvic ureter in 1 case.

[Esthetic and functional results of the transperitoneal laparoscopic approach in nephrectomy].

Objective: To evaluate the aesthetic and functional sequelae of laparoscopic transperitoneal nephrectomy.

Material And Methods: Twenty-one laparoscopic transperitoneal nephrectomies were performed between 1996 and 1999. Four trocars were used in 9 patients and 3 trocars were used in 12 patients.

Scintigraphic screening for renal damage in siblings of children with symptomatic primary vesico-ureteric reflux.

Objective: To define prospectively the incidence of renal parenchymal lesions in the siblings of patients treated at one institution for primary vesico-ureteric reflux (VUR).

Patients And Methods: From January 1997 to October 1998, a prospective study including renal scintigraphy (using dimercaptosuccinic acid, DMSA) and a radionuclide cystogram was proposed systematically to the asymptomatic siblings of children treated for primary VUR. The radionuclide cystograms were interpreted as showing the presence or absence of VUR and the DMSA scan as symmetrical or asymmetrical differential function, with or with no renal defect.

Laparoscopic retroperitoneal nephrectomy in high risk children.

Purpose: Nephrectomy may be indicated in children with end stage renal disease before transplantation. We studied the feasibility and results of nephrectomy performed via a retroperitoneal laparoscopic approach in these high risk children.

Materials And Methods: We performed 12 nephrectomies in 9 children with end stage renal disease and a mean age of 7 years (range 7 months to 13 years) through a 3 trocar retroperitoneal laparoscopic approach.

Urolithiasis and the protease inhibitor indinavir.

Objective: To evaluate specific urological abnormalities in patients treated with the protease inhibitor indinavir.

Methods: A series of 155 consecutive human immunodeficiency virus-positive patients were treated with indinavir 800 mg p.o.